IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 52.91

Change

+0.56 (+1.07)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+1.08 (+0.74%)

USD 40.26B
FHLC Fidelity® MSCI Health Care In..

+0.58 (+0.83%)

USD 2.86B
FXH First Trust Health Care AlphaD..

+1.32 (+1.22%)

USD 1.19B
XHE SPDR® S&P Health Care Equipme..

+1.47 (+1.64%)

USD 0.21B
IDNA iShares Genomics Immunology an..

+0.18 (+0.71%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

+0.83 (+2.15%)

USD 0.12B
XHS SPDR® S&P Health Care Service..

+0.94 (+1.00%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

+0.32 (+1.10%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

+0.78 (+1.21%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.30 (+1.03%)

USD 0.01B

ETFs Containing IHF

MSSS 9.54 % 0.00 %

N/A

N/A
LCR Leuthold Core ETF 0.00 % 0.00 %

+0.28 (+0%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -79.85% 10% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -79.85% 10% F 3% F
Trailing 12 Months  
Capital Gain -78.90% 5% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -78.90% 5% F 3% F
Trailing 5 Years  
Capital Gain -71.07% 10% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -71.07% 10% F 7% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.17% 71% C- 61% D-
Dividend Return 7.80% 71% C- 55% F
Total Return 0.62% 63% D 15% F
Risk Return Profile  
Volatility (Standard Deviation) 20.62% 48% F 52% F
Risk Adjusted Return 37.82% 62% D 55% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.